Section 1833(t)(14)(A)(iii) of the Act required the Secretary to set payment rates for specified covered outpatient drugs (SCODs) [526] beginning in 2006 at the amount the Secretary determined to be the average acquisition cost for the drug for that year, at least when certain hospital acquisition cost survey data is available
According to Hayward et al
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): A 52-week, phase 2/3a, randomised, controlled trial
Thats how GLP-1s entered the weight loss conversation
How It Works Users begin with an online questionnaire, followed by a virtual consult with a licensed provider
But cost should be weighed alongside the other factors below, not treated as the only variable